Concepedia

Dennis Monteleone

DM

5

Publications

245

Citations

5

H-Index

2015

Active since

Affiliations

SiteOne Therapeutics (United States)(Current)

Stanford University

Purdue University West Lafayette

Center for Cancer Research

Dennis Monteleone is an author at SiteOne Therapeutics (United States) specializing in drug discovery, drug resistance, and antimicrobial drug discovery.

ORCID

Top concepts

Publications per year

2015–2024

5

Publications

5

Synthesis and antibacterial evaluation of a novel series of synthetic phenylthiazole compounds against methicillin-resistant Staphylococcus aureus (MRSA)

Haroon Mohammad, P. Venkat Reddy, Dennis Monteleone et al. · European Journal of Medicinal Chemistry · 2015 · 96 citations · Full text

, , +11

Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius

Haroon Mohammad, P. Venkat Reddy, Dennis Monteleone et al. · PLoS ONE · 2015 · 61 citations · Full text

, , +20

Discovery of a selective, state-independent inhibitor of NaV1.7 by modification of guanidinium toxins

Hassan Pajouhesh, Jacob T. Beckley, Anton Delwig et al. · Scientific Reports · 2020 · 40 citations · Full text

Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain

Jacob T. Beckley, Hassan Pajouhesh, George Luu et al. · Pain · 2020 · 36 citations · Full text

ST‐2560, a selective inhibitor of the Na<sub>V</sub>1.7 sodium channel, affects nocifensive and cardiovascular reflexes in non‐human primates

John V. Mulcahy, Jacob T. Beckley, Sheri Klas et al. · British Journal of Pharmacology · 2024 · 12 citations

Rows per page

1–5 of 5